# Remission Evaluation of a Metabolic Intervention in Type 2 Diabetes With Forxiga

> **NCT02561130** · PHASE4 · COMPLETED · sponsor: **Population Health Research Institute** · enrollment: 154 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** insulin glargine
- **DRUG:** metformin
- **DRUG:** Forxiga
- **BEHAVIORAL:** Lifestyle therapy

## Key facts

- **NCT ID:** NCT02561130
- **Lead sponsor:** Population Health Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12
- **Primary completion:** 2017-07
- **Final completion:** 2018-12-31
- **Target enrollment:** 154 (ACTUAL)
- **Last updated:** 2020-11-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02561130

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02561130, "Remission Evaluation of a Metabolic Intervention in Type 2 Diabetes With Forxiga". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02561130. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*